1. Home
  2. Directory
  3. New Jersey
  4. Edison
  5. Physical Medicine Rehabilitation
  6. NPI Profile
  7. Prescriptions 1720004625

DR. STEVEN ESCALDI D.O.
Prescription History 1720004625
Physical Medicine & Rehabilitation in Edison, NJ


Quality Rating: 75.8 out of 100 score

NPI Status: Active since July 14, 2006

Contact Information

65 JAMES ST
EDISON, NJ
ZIP 08820
Phone: (732) 321-7000
Fax: (732) 321-7330

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. STEVEN ESCALDI D.O., an active Physical Medicine & Rehabilitation specialist practicing in Edison, NJ. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 350 documented patient claims. Among these therapy options, the most frequently utilized medication is Baclofen, which accounts for 137 claims alone.

Medication Index

Alprazolam

Generic Formulation: AlprazolamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
NJ State Average Benchmarks
Peer Average Claims76.0
Peer Average 30-Day Fills86.3
Peer Average Days Supply2,379
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.2% less volume than the regional standard for practitioners inside NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $240.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.00

State Avg Cost Per Claim

$10.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)

Therapeutic Applications

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Baclofen

Generic Formulation: BaclofenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 137
30-Day Fills 201.0
Days Supply 5,988
NJ State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills43.5
Peer Average Days Supply1,191
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 315.2% higher than the standard regional baseline profile for NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,294.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.35

State Avg Cost Per Claim

$32.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Clonazepam

Generic Formulation: ClonazepamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.1
Days Supply 564
NJ State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills61.0
Peer Average Days Supply1,709
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.8% less volume than the regional standard for practitioners inside NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $148.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.84

State Avg Cost Per Claim

$10.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

Therapeutic Applications

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

Dantrolene Sodium

Generic Formulation: Dantrolene SodiumSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 20
30-Day Fills 34.0
Days Supply 1,020
NJ State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills18.6
Peer Average Days Supply472
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,228.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$111.42

State Avg Cost Per Claim

$76.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.

Therapeutic Applications

This medication is used to treat muscle tightness and cramping (spasms) caused by certain nerve disorders such as spinal cord injury, stroke, cerebral palsy, and multiple sclerosis. It works by relaxing the muscles. Dantrolene helps reduce muscle pain and stiffness, improves your ability to move around, and lets you do more of your daily activities. Dantrolene is also used with other treatments to prevent or treat special cases of high fever (malignant hyperthermia) related to anesthesia and surgery.

Diazepam

Generic Formulation: DiazepamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 32
30-Day Fills 32.0
Days Supply 795
NJ State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills29.9
Peer Average Days Supply777
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $81.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.54

State Avg Cost Per Claim

$9.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

Therapeutic Applications

This medication is used to treat episodes of increased seizures (such as cluster or breakthrough seizures) in people who are already taking medications to control their seizures. This product is only recommended for short-term treatment of seizure attacks. It is not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious (possibly fatal) seizures that do not stop (status epilepticus). This medication is not recommended for children younger than 6 months of age because of the risk of serious side effects. Diazepam works by calming the brain and nerves. It belongs to a class of drugs known as benzodiazepines.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 42
30-Day Fills 50.0
Days Supply 1,500
NJ State Average Benchmarks
Peer Average Claims73.0
Peer Average 30-Day Fills109.8
Peer Average Days Supply3,196
Conservative Utilization

This provider writes prescriptions for this formulation 42.5% less frequently than the standard regional baseline metric for practitioners inside NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $835.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.89

State Avg Cost Per Claim

$19.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Lioresal Intrathecal

Generic Formulation: BaclofenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 11
NJ State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills14.0
Peer Average Days Supply14
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,545.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,049.61

State Avg Cost Per Claim

$1,015.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 160
NJ State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills56.9
Peer Average Days Supply1,160
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 71.4% less volume than the regional standard for practitioners inside NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $243.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.19

State Avg Cost Per Claim

$23.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 61
30-Day Fills 63.0
Days Supply 1,859
NJ State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills54.3
Peer Average Days Supply1,468
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 41.9% more claims than the standard regional baseline profile for NJ. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,093.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.93

State Avg Cost Per Claim

$15.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. STEVEN ESCALDI D.O. provides transparency into local medical care patterns within Edison, NJ.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physical Medicine & Rehabilitation** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.